BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34900728)

  • 1. Multiple Survival Outcome Prediction of Glioblastoma Patients Based on Multiparametric MRI.
    Wang B; Zhang S; Wu X; Li Y; Yan Y; Liu L; Xiang J; Li D; Yan T
    Front Oncol; 2021; 11():778627. PubMed ID: 34900728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A radiomics nomogram based on multiparametric MRI might stratify glioblastoma patients according to survival.
    Zhang X; Lu H; Tian Q; Feng N; Yin L; Xu X; Du P; Liu Y
    Eur Radiol; 2019 Oct; 29(10):5528-5538. PubMed ID: 30847586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Multiparametric MRI-Based Radiomics Nomogram for Preoperative Prediction of Survival Stratification in Glioblastoma Patients With Standard Treatment.
    Jia X; Zhai Y; Song D; Wang Y; Wei S; Yang F; Wei X
    Front Oncol; 2022; 12():758622. PubMed ID: 35251957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Improvement of Survival Stratification in Glioblastoma Patients via Combining Subregional Radiomics Signatures.
    Yang Y; Han Y; Hu X; Wang W; Cui G; Guo L; Zhang X
    Front Neurosci; 2021; 15():683452. PubMed ID: 34054424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Validation of a MRI-Based Radiomics Prognostic Classifier in Patients with Primary Glioblastoma Multiforme.
    Chen X; Fang M; Dong D; Liu L; Xu X; Wei X; Jiang X; Qin L; Liu Z
    Acad Radiol; 2019 Oct; 26(10):1292-1300. PubMed ID: 30660472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiomics Analysis Based on Magnetic Resonance Imaging for Preoperative Overall Survival Prediction in Isocitrate Dehydrogenase Wild-Type Glioblastoma.
    Wang S; Xiao F; Sun W; Yang C; Ma C; Huang Y; Xu D; Li L; Chen J; Li H; Xu H
    Front Neurosci; 2021; 15():791776. PubMed ID: 35153659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glioblastoma and Solitary Brain Metastasis: Differentiation by Integrating Demographic-MRI and Deep-Learning Radiomics Signatures.
    Zhang Y; Zhang H; Zhang H; Ouyang Y; Su R; Yang W; Huang B
    J Magn Reson Imaging; 2023 Nov; ():. PubMed ID: 37955154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiregional radiomics profiling from multiparametric MRI: Identifying an imaging predictor of IDH1 mutation status in glioblastoma.
    Li ZC; Bai H; Sun Q; Zhao Y; Lv Y; Zhou J; Liang C; Chen Y; Liang D; Zheng H
    Cancer Med; 2018 Dec; 7(12):5999-6009. PubMed ID: 30426720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Machine Learning Based on a Multiparametric and Multiregional Radiomics Signature Predicts Radiotherapeutic Response in Patients with Glioblastoma.
    Pan ZQ; Zhang SJ; Wang XL; Jiao YX; Qiu JJ
    Behav Neurol; 2020; 2020():1712604. PubMed ID: 33163122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep Learning Radiomics for the Assessment of Telomerase Reverse Transcriptase Promoter Mutation Status in Patients With Glioblastoma Using Multiparametric MRI.
    Zhang H; Zhang H; Zhang Y; Zhou B; Wu L; Lei Y; Huang B
    J Magn Reson Imaging; 2023 Nov; 58(5):1441-1451. PubMed ID: 36896953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiparametric magnetic resonance imaging-derived radiomics for the prediction of disease-free survival in early-stage squamous cervical cancer.
    Zhou Y; Gu HL; Zhang XL; Tian ZF; Xu XQ; Tang WW
    Eur Radiol; 2022 Apr; 32(4):2540-2551. PubMed ID: 34642807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Nomogram of MRI-based Radiomics with Complementary Visual Features by Machine Learning Improves Stratification of Glioblastoma Patients: A Multicenter Study.
    Xu Y; He X; Li Y; Pang P; Shu Z; Gong X
    J Magn Reson Imaging; 2021 Aug; 54(2):571-583. PubMed ID: 33559302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiregional radiomics features from multiparametric MRI for prediction of MGMT methylation status in glioblastoma multiforme: A multicentre study.
    Li ZC; Bai H; Sun Q; Li Q; Liu L; Zou Y; Chen Y; Liang C; Zheng H
    Eur Radiol; 2018 Sep; 28(9):3640-3650. PubMed ID: 29564594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiomics may increase the prognostic value for survival in glioblastoma patients when combined with conventional clinical and genetic prognostic models.
    Choi Y; Nam Y; Jang J; Shin NY; Lee YS; Ahn KJ; Kim BS; Park JS; Jeon SS; Hong YG
    Eur Radiol; 2021 Apr; 31(4):2084-2093. PubMed ID: 33006658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiparametric MRI-based fusion radiomics for predicting telomerase reverse transcriptase (TERT) promoter mutations and progression-free survival in glioblastoma: a multicentre study.
    Zhang H; Zhang H; Zhang Y; Zhou B; Wu L; Yang W; Lei Y; Huang B
    Neuroradiology; 2024 Jan; 66(1):81-92. PubMed ID: 37978079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining Multiparametric MRI Radiomics Signature With the Vesical Imaging-Reporting and Data System (VI-RADS) Score to Preoperatively Differentiate Muscle Invasion of Bladder Cancer.
    Zheng Z; Xu F; Gu Z; Yan Y; Xu T; Liu S; Yao X
    Front Oncol; 2021; 11():619893. PubMed ID: 34055600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival Outcome Prediction in Glioblastoma: Insights from MRI Radiomics.
    Styliara EI; Astrakas LG; Alexiou G; Xydis VG; Zikou A; Kafritsas G; Voulgaris S; Argyropoulou MI
    Curr Oncol; 2024 Apr; 31(4):2233-2243. PubMed ID: 38668068
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of MRI radiomics-based machine learning survival models in predicting prognosis of glioblastoma multiforme.
    Zhang D; Luan J; Liu B; Yang A; Lv K; Hu P; Han X; Yu H; Shmuel A; Ma G; Zhang C
    Front Med (Lausanne); 2023; 10():1271687. PubMed ID: 38098850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiomics Analysis of PET and CT Components of
    Wang X; Lu Z
    Front Oncol; 2021; 11():638124. PubMed ID: 33928029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a multiparametric MRI-based radiomics signature for distinguishing between indolent and aggressive prostate cancer.
    Zhang L; Jiang D; Chen C; Yang X; Lei H; Kang Z; Huang H; Pang J
    Br J Radiol; 2022 Mar; 95(1131):20210191. PubMed ID: 34289319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.